Chinese medical device company Yuwell Medical made its debut at CES 2026 this week (Las Vegas, Jan. 6-9), showcasing its portfolio of health management products.

The lineup comprised wearables as well as solutions for respiratory health, chronic disease management, and first aid. Respiratory products included the Pocket S portable breathcare device and SP-6Pro portable oxygen concentrator, both of which offer mobility options. The YE699 fully automatic electronic blood pressure monitor, on the other hand, aim to improve chronic disease management via precision and intelligence.

Making its first public appearance, the Yuwell R3 Health Ring became a booth highlight. Crafted from titanium alloy and medical-grade resin, it features an ultra-lightweight design with a skin-friendly finish for all-day comfort. The ring allows users to continuously monitor multi-dimensional vital signs, including sleep, heart rate, blood oxygen levels, and physical activity. Powered by artificial intelligence (AI)-driven health insights and abnormal condition alerts, it also delivers a seven-day battery life under regular use.

Yuwell has partnered with several professional medical institutions to combine its sensor technologies—developed over more than 20 years of experience in medical-grade monitoring of blood oxygen, heart rate, and sleep—with proprietary AI algorithms. This effort addresses a longstanding challenge in wearable technology of balancing data accuracy, wearing comfort, and actionable health insights.

Yuwell Medical’s participation at CES reflects its vision for the evolution of AI-driven health devices, according to company bigwigs. Artificial intelligence is transforming medical monitoring tools from simple “data recorders” into intelligent health stewards. This transformation is unfolding across four key dimensions: first, achieving medical-grade precision by upgrading devices from providing reference data to delivering reliable health analysis and insights; second, enhancing invisibility by seamlessly integrating health monitoring into daily life through ultra-thin and lightweight wearable designs; third, enabling predictiveness by shifting from retrospective data tracking to early risk warnings through AI modeling; and fourth, building a systematic ecosystem in which devices function as collaborative nodes connecting personal and family health management.

“Our product innovation is closely aligned with our core strategies of globalization, digitalization, and wearability,” said Hua Hao, general manager of Yuwell’s AI Wearable Medical Business. “By integrating hardware, algorithms, and services, we are extending professional monitoring and evaluation—once limited to hospital settings—into everyday life, enabling a prevention-first, closed-loop health management approach.”

Yuwell Medical is headquartered in Nanjing, China, with subsidiaries, R&D, and manufacturing facilities worldwide. The company has built a comprehensive medical service platform, bringing professional medical technologies and advanced product solutions into daily life, creating a health ecosystem merging homecare, clinical treatment, and online solutions.

Yuwell Medical has a 26-year history of establishing industry standards and providing products for homecare and chronic disease management. Its product development expertise encompasses respiratory therapy, diabetes management, medical diagnostic equipment, AEDs, medical imaging, and traditional Chinese medicine, among others.